Annexin Pharmaceuticals AB (publ)

kr 8.90As of Sun 8 Nov 2026, 12:00 UTC
STO:ANNXHealthcare
Country Sweden
PE (Fwd) •••
TSR 10Y CAGR (31.22%)
Div yield —
ROE (176.14%)
Biotechnology
Beta (5Y) 0.43
PE TTM —
TSR TTM (65.78%)
Mkt cap kr 77.59M
ROIC (109.90%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
kr 11
26.48%
81.27%
Buy 10|1|1|9|1
4Q25
1Q26
2Q26
3Q26
Earnings per sharekr
0.13
0.13
0.15
0.16
(1.26%)
3.98%
18.32%
35.03%
Revenuekr M
5.451
5.521
5.598
5.677
7.88%
8.58%
7.16%
3.41%
Peers (US$7.845M)
Cap (US$)
PE
7.876M
—
Capital
TTM
5Y
10Y
Leveragex
0.599
(0.742)
(0.652)
EBIT/Intx
0.636
0.119
0.118
Own earn%
(87.13)
(94.33)
(107.19)
Sh yield%
18.58
35.82
44.26
Owners
Insiders/Inst%
4.21
36.26
Short interest%
1.01
SBC / revenue%
3.36
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
3
Op margin range%
0–1
$1 testx
—
Incr. ROIC%
6